AI-assisted analysis of the earnings call, per our editorial policy. Informational only — not investment advice.

Aehr (AEHR) Q4 2023: $78M Bookings Signal Multi-Customer Silicon Carbide Ramp

Aehr Test Systems enters fiscal 2024 with record backlog and growing customer diversification, leveraging breakout demand for wafer-level test and burn-in in silicon carbide and photonics. The company’s guidance and operational buildout point to accelerating adoption across electric vehicle, industrial, and optical I/O markets. Investors should focus on execution against a swelling pipeline and the pace of new customer ramps as the addressable market expands.

Summary

  • Silicon Carbide Expansion: Aehr is broadening its customer base beyond a single dominant account, positioning for sustained growth in power semiconductors.
  • Automation and High-Voltage Innovation: New automated aligner and high-voltage test modules unlock incremental markets and operational leverage.
  • Guidance Anchored by Visibility: Management’s $100M+ outlook reflects confidence in backlog and pipeline, but customer ramp timing remains a key variable.

Business Overview

Aehr Test Systems provides wafer-level test and burn-in solutions for the semiconductor industry, focusing on high-reliability applications such as electric vehicles (EVs), industrial power, and silicon photonics. Its core revenue streams derive from the sale of FOX XP and NP multi-wafer test systems, proprietary WaferPak full-wafer contactors, and consumables. Key segments include silicon carbide (SiC) devices for EV and industrial markets, and silicon photonics for data and telecommunications infrastructure. Aehr’s business model leverages both system sales and recurring consumable revenue, with a growing emphasis on automation and high-voltage testing capabilities.

Performance Analysis

Aehr delivered a record year, with revenue, bookings, and profits all reaching new highs, driven primarily by the accelerating adoption of wafer-level test and burn-in for silicon carbide semiconductors. The business remains highly concentrated, with two customers accounting for 89% of revenue (one at 79%, another at 10%), but management anticipates broader customer participation in fiscal 2024. The company’s backlog nearly doubled, and bookings momentum carried into the new year, with $15 million booked in the first six weeks of Q1.

Gross margin held steady above 50%, despite increased operating expenses tied to R&D and expanded sales initiatives. The company’s cash position strengthened, with operating cash flow up sharply and no debt on the balance sheet. Importantly, consumables (WaferPak and DiePak) represented 38% of Q4 revenue, reflecting the recurring nature of the installed base. The mix shift between systems and consumables will remain a key metric as new customers ramp.

  • Customer Concentration Remains High: The lead SiC customer contributed 79% of revenue, but new wins are expected to dilute this over time.
  • Consumables as Recurring Engine: WaferPak and DiePak sales provide a sticky, margin-accretive revenue stream as the installed base grows.
  • Cash Generation Surges: Operating cash flow increased more than 800% YoY, supporting R&D and capacity expansion.

Execution will hinge on the pace of new customer ramps and the ability to meet rising demand across multiple verticals, especially as management forecasts at least 50% revenue growth and nearly doubling net income in fiscal 2024.

Executive Commentary

"We start fiscal 2024 with an effective backlog of almost $40 million and a strong forecast from our current and prospective customers. Our engagements with numerous potential new customers gives us confidence in our growth expectations over the next several years including projections for record revenue and profit again for this fiscal year that ends next May, particularly as the positive momentum and demand for silicon carbide and electric vehicle continues to accelerate."

Gayn Erickson, President and CEO

"We generated a record $10 million in operating cash flows in fiscal 2023, up more than 500% from the prior year. In the fiscal year, demand for our products was very strong with record annual bookings of $78.3 million, up 30% from our total bookings of $60.2 million for the prior fiscal year."

Chris Swee, Chief Financial Officer

Strategic Positioning

1. Silicon Carbide Market Penetration

Aehr is rapidly expanding its presence in the silicon carbide test market, adding four new SiC customers this year and capturing follow-on orders from existing accounts. The company is positioned to benefit from the projected 20x growth in SiC wafer demand for EVs and industrial applications by 2030, with its FOX XP systems and WaferPak contactors serving as the core platform for high-volume, high-reliability testing.

2. Automation and High-Voltage Differentiation

The introduction of the fully automated WaferPak aligner and high-voltage channel modules extends Aehr’s addressable market and operational leverage. Automation enables hands-free, lights-out operations for customers scaling to high volumes, while new voltage capabilities unlock applications in gallium nitride (GaN) and advanced SiC devices. These innovations support both cost competitiveness and entry into adjacent markets.

3. Silicon Photonics and Optical I/O

Silicon photonics is emerging as a parallel growth engine, with major semiconductor manufacturers adopting Aehr’s FOX XP systems for next-generation optical I/O and co-packaged optics. The ability to test and burn-in high power-density photonic integrated circuits at wafer scale is a unique differentiator, positioning Aehr to capture future growth in data center and AI connectivity applications.

4. Customer Diversification and Pipeline Visibility

Management expects to move from one dominant customer to three or four 10%+ customers in FY24, reducing risk and broadening the revenue base. The sales funnel includes both new bookings and “turns” customers (book-and-ship within the year), with visibility supported by customer plant expansions and public capacity plans. However, the timing of new ramps remains inherently variable.

5. Capacity Expansion and Supply Chain Readiness

Production capacity was tripled in fiscal 2023, with plans to double again by year-end to ensure short lead times and high-volume support. Management cites supply chain and infrastructure readiness as a competitive advantage, ensuring Aehr can meet demand if “everyone shows up.”

Key Considerations

Aehr’s breakout year is underpinned by a major inflection in SiC and photonics demand, but the next phase will test the company’s ability to scale, diversify, and maintain technology leadership. Investors should monitor:

Key Considerations:

  • Customer Ramp Timing: The pace at which new SiC and photonics customers move from evaluation to high-volume production will drive revenue realization and mix.
  • Recurring Consumables Growth: As the installed base expands, consumable sales should increase, supporting margin stability and revenue visibility.
  • Operating Leverage vs. Cost Inflation: While gross margins are resilient, expanded OpEx for R&D, sales, and regulatory compliance will pressure the breakeven point upward.
  • Technology Adoption in Adjacent Markets: Success in GaN, photonics, and potential memory applications could provide upside and reduce reliance on SiC.

Risks

Customer concentration remains a material risk, though management expects improved diversification in the coming year. The timing and magnitude of new customer ramps are inherently uncertain, with large system orders subject to delays or lumpy demand. Increased OpEx tied to regulatory requirements and R&D could pressure margins if revenue growth slows. Competitive dynamics in wafer-level burn-in, especially from larger ATE providers, could intensify as the market expands.

Forward Outlook

For fiscal 2024, Aehr guided to:

  • Revenue of at least $100 million (over 50% growth YoY)
  • GAAP net income of at least $28 million (over 90% growth YoY)

Management highlighted several factors that support the outlook:

  • Backlog of nearly $40 million entering the year, with strong forecast visibility from current and new customers
  • Expectation of three to four 10%+ customers, reducing revenue concentration risk

Takeaways

Aehr’s scale-up in SiC and photonics test positions the company for multi-year growth, but execution risk around customer ramps and operational scaling remains high. The company’s technology differentiation in wafer-level burn-in and automation is clear, but the competitive landscape and customer dynamics will shape the next phase.

  • Multi-Customer Expansion: Growth will increasingly depend on new customer ramps and the breadth of adoption in SiC and photonics, not just the lead account.
  • Operational Readiness: Investments in automation and capacity expansion are necessary to capture market share as demand accelerates.
  • Pipeline Visibility and Execution: Investors should watch for the conversion of pipeline opportunities into bookings and recurring consumable revenue, as well as margin resilience amid rising OpEx.

Conclusion

Aehr enters fiscal 2024 with record momentum, a robust order book, and a clear path to customer diversification. Technology leadership in wafer-level test and burn-in, combined with automation and high-voltage innovation, underpins a compelling growth narrative—if execution keeps pace with market opportunity.

Industry Read-Through

The surge in SiC test demand confirms the secular growth of electric vehicle and industrial power electronics, with wafer-level burn-in emerging as a critical bottleneck and value-add for device reliability. Silicon photonics adoption in AI and data center connectivity is gaining momentum, with large semiconductor OEMs signaling future volume ramps. Automation and high-voltage test capabilities are becoming table stakes for suppliers serving high-mix, high-reliability markets. Competitors and adjacent players in semiconductor capital equipment should monitor Aehr’s customer wins, backlog growth, and technology adoption as leading indicators of broader industry shifts toward wafer-level quality assurance and integrated automation.